Symbols / ROIV $29.34 +0.17% Roivant Sciences Ltd.
ROIV Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Market Cap | 20.86B | Enterprise Value | — | Income | — | Sales | — | Book/sh | — | Cash/sh | — |
| Dividend Yield | — | Payout | — | Employees | — | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | — | P/B | — | P/C | — | EV/EBITDA | — | EV/Sales | — |
| Quick Ratio | — | Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | — | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | — | ROA | — | ROE | — | ROIC | — |
| Gross Margin | — | Oper. Margin | — | Profit Margin | — | Shs Outstand | — | Shs Float | — | Short Float | — |
| Short Ratio | — | Short Interest | — | 52W High | — | 52W Low | — | Beta | — | Avg Volume | — |
| Volume | — | Target Price | — | Recom | — | Prev Close | $29.29 | Price | $29.34 | Change | 0.17% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- Roivant (NASDAQ: ROIV) president exercises 200K options, sells shares - Stock Titan Wed, 22 Apr 2026 22
- Insider Sale: CEO of $ROIV Sells 289,774 Shares - Quiver Quantitative Mon, 20 Apr 2026 22
- Roivant Sciences(ROIV.US) Officer Sells US$5.92 Million in Common Stock - Moomoo Wed, 22 Apr 2026 22
- Top Biotech Insider Makes Bold Multi-Million Dollar Stock Move - TipRanks hu, 23 Apr 2026 02
- Roivant Sciences (ROIV) CFO awarded 60,644 RSUs and 84,026 stock options - Stock Titan Wed, 22 Apr 2026 22
- Roivant Sciences (ROIV) Valuation Check After Strong Share Price Momentum - Yahoo Finance Sun, 08 Feb 2026 08
- Roivant (ROIV) Stock Insider Ownership (Smart Money Outflows) 2026-04-20 - Shared Trade Alerts - Xã Vĩnh Công Mon, 20 Apr 2026 15
- Roivant Sciences Ltd. (ROIV) Wins Orphan Drug Status in Japan for Mosliciguat - MSN Sat, 18 Apr 2026 17
- ROIV Maintained by Piper Sandler -- Price Target Raised to $40 - GuruFocus Fri, 17 Apr 2026 03
- ROIV | Roivant Sciences Ltd. Common Executive Compensation - Quiver Quantitative Sat, 04 Apr 2026 14
- Roivant Sciences (ROIV): Evaluating Valuation After Strong Share Price Momentum in Biotech - Yahoo Finance Wed, 29 Oct 2025 07
- Roivant Sciences Rocked by Major Insider Stock Sale from Its CEO - TipRanks ue, 21 Apr 2026 02
- Roivant Sciences (ROIV) director gets share award, settles taxes in stock - Stock Titan Wed, 22 Apr 2026 01
- Do You Believe in the Growth Prospects of Roivant Sciences Ltd. (ROIV)? - Yahoo Finance ue, 04 Nov 2025 08
- Insider Sale: Director at $ROIV Sells 432,718 Shares | ROIV Stock News - Quiver Quantitative Fri, 19 Dec 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
29.05
-11.19%
|
32.71
+3.75%
|
31.53
-42.97%
|
55.29
|
| Operating Revenue |
|
29.05
-11.19%
|
32.71
+3.75%
|
31.53
-42.97%
|
55.29
|
| Cost Of Revenue |
|
0.91
-43.03%
|
1.60
-47.30%
|
3.03
-66.16%
|
8.97
|
| Reconciled Cost Of Revenue |
|
0.91
-43.03%
|
1.60
-47.30%
|
3.03
-66.16%
|
8.97
|
| Gross Profit |
|
28.14
-9.55%
|
31.11
+9.19%
|
28.50
-38.48%
|
46.32
|
| Operating Expense |
|
1,141.82
+33.38%
|
856.04
+2.21%
|
837.51
-33.43%
|
1,258.07
|
| Research And Development |
|
550.41
+25.12%
|
439.91
-3.12%
|
454.06
-6.00%
|
483.04
|
| Selling General And Administration |
|
591.41
+42.12%
|
416.13
+8.52%
|
383.45
-50.52%
|
775.03
|
| General And Administrative Expense |
|
591.41
+42.12%
|
416.13
+8.52%
|
383.45
-50.52%
|
775.03
|
| Other Gand A |
|
591.41
+42.12%
|
416.13
+8.52%
|
383.45
-50.52%
|
775.03
|
| Total Expenses |
|
1,142.73
+33.24%
|
857.64
+2.03%
|
840.54
-33.66%
|
1,267.03
|
| Operating Income |
|
-1,113.68
-35.00%
|
-824.93
-1.97%
|
-809.01
+33.24%
|
-1,211.75
|
| Total Operating Income As Reported |
|
-1,003.29
-122.31%
|
4,497.03
+595.94%
|
-906.76
+32.91%
|
-1,351.64
|
| EBITDA |
|
-1,099.61
-36.96%
|
-802.89
-1.61%
|
-790.16
+13.24%
|
-910.77
|
| Normalized EBITDA |
|
-1,268.29
+79.24%
|
-6,109.65
-771.73%
|
-700.87
+41.54%
|
-1,198.86
|
| Reconciled Depreciation |
|
14.07
-36.15%
|
22.04
+16.86%
|
18.86
+217.89%
|
5.93
|
| EBIT |
|
-1,113.68
-35.00%
|
-824.93
-1.97%
|
-809.01
+11.75%
|
-916.71
|
| Total Unusual Items |
|
168.68
-96.82%
|
5,306.76
+6043.42%
|
-89.29
-130.99%
|
288.08
|
| Total Unusual Items Excluding Goodwill |
|
168.68
-96.82%
|
5,306.76
+6043.42%
|
-89.29
-130.99%
|
288.08
|
| Special Income Charges |
|
113.50
-97.88%
|
5,354.73
+7920.21%
|
-68.47
-0.13%
|
-68.38
|
| Other Special Charges |
|
—
|
26.45
-72.94%
|
97.75
+33.13%
|
73.42
|
| Restructuring And Mergern Acquisition |
|
—
|
26.45
-72.94%
|
97.75
-30.13%
|
139.89
|
| Net Income |
|
-171.98
-103.95%
|
4,348.93
+531.00%
|
-1,009.03
-19.37%
|
-845.26
|
| Pretax Income |
|
-681.59
-114.92%
|
4,567.86
+616.15%
|
-884.99
+4.20%
|
-923.75
|
| Net Non Operating Interest Income Expense |
|
258.38
+76.46%
|
146.43
+354.96%
|
32.18
+582.37%
|
-6.67
|
| Interest Expense Non Operating |
|
—
|
34.78
+24.35%
|
27.97
+297.22%
|
7.04
|
| Net Interest Income |
|
258.38
+76.46%
|
146.43
+354.96%
|
32.18
+582.37%
|
-6.67
|
| Interest Expense |
|
—
|
34.78
+24.35%
|
27.97
+297.22%
|
7.04
|
| Interest Income Non Operating |
|
258.38
+76.46%
|
146.43
+354.96%
|
32.18
+8621.95%
|
0.37
|
| Interest Income |
|
258.38
+76.46%
|
146.43
+354.96%
|
32.18
+8621.95%
|
0.37
|
| Other Income Expense |
|
173.72
-96.69%
|
5,246.36
+4950.55%
|
-108.16
-136.71%
|
294.67
|
| Other Non Operating Income Expenses |
|
5.04
+108.34%
|
-60.40
-220.05%
|
-18.87
-386.33%
|
6.59
|
| Gain On Sale Of Security |
|
55.19
+215.04%
|
-47.97
-130.47%
|
-20.82
-105.84%
|
356.46
|
| Gain On Sale Of Business |
|
113.50
-97.89%
|
5,381.18
+18280.86%
|
29.28
+480.76%
|
5.04
|
| Tax Provision |
|
48.17
+124.03%
|
21.50
+426.78%
|
4.08
+1006.23%
|
0.37
|
| Tax Rate For Calcs |
|
0.00
+5219.15%
|
0.00
-97.53%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
42.17
+69.07%
|
24.94
+247.02%
|
-16.96
-130.99%
|
54.74
|
| Net Income Including Noncontrolling Interests |
|
-356.73
-108.43%
|
4,231.21
+479.32%
|
-1,115.46
-20.71%
|
-924.12
|
| Net Income From Continuing Operation Net Minority Interest |
|
-545.01
-111.69%
|
4,664.07
+695.94%
|
-782.64
+7.41%
|
-845.26
|
| Net Income From Continuing And Discontinued Operation |
|
-171.98
-103.95%
|
4,348.93
+531.00%
|
-1,009.03
-19.37%
|
-845.26
|
| Net Income Continuous Operations |
|
-729.76
-116.05%
|
4,546.35
+611.36%
|
-889.07
+3.79%
|
-924.12
|
| Net Income Discontinuous Operations |
|
373.03
+218.37%
|
-315.15
-39.20%
|
-226.39
|
0.00
|
| Minority Interests |
|
184.75
+56.94%
|
117.72
+10.60%
|
106.43
+34.97%
|
78.85
|
| Normalized Income |
|
-671.52
-8.71%
|
-617.74
+13.03%
|
-710.32
+34.15%
|
-1,078.61
|
| Net Income Common Stockholders |
|
-171.98
-103.95%
|
4,348.93
+531.00%
|
-1,009.03
-19.37%
|
-845.26
|
| Diluted EPS |
|
-0.24
-104.59%
|
5.23
+468.31%
|
-1.42
-12.70%
|
-1.26
|
| Basic EPS |
|
-0.24
-104.59%
|
5.23
+468.31%
|
-1.42
-12.70%
|
-1.26
|
| Basic Average Shares |
|
725.40
-7.39%
|
783.25
+9.88%
|
712.79
+6.43%
|
669.75
|
| Diluted Average Shares |
|
725.40
-12.71%
|
831.05
+16.59%
|
712.79
+6.43%
|
669.75
|
| Diluted NI Availto Com Stockholders |
|
-171.98
-103.95%
|
4,348.93
+531.00%
|
-1,009.03
-19.37%
|
-845.26
|
| Earnings From Equity Interest |
|
—
|
—
|
—
|
0.00
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets |
|
5,436.94
-24.72%
|
7,222.48
+202.25%
|
2,389.60
-7.56%
|
2,585.13
|
| Current Assets |
|
5,000.06
-25.73%
|
6,731.83
+274.28%
|
1,798.59
-16.21%
|
2,146.52
|
| Cash Cash Equivalents And Short Term Investments |
|
4,886.89
-24.76%
|
6,494.95
+287.34%
|
1,676.81
-18.62%
|
2,060.40
|
| Cash And Cash Equivalents |
|
2,715.41
-58.19%
|
6,494.95
+287.34%
|
1,676.81
-18.62%
|
2,060.40
|
| Cash Equivalents |
|
2,621.46
-58.47%
|
6,312.29
|
—
|
—
|
| Cash Financial |
|
93.95
-48.56%
|
182.66
|
—
|
—
|
| Other Short Term Investments |
|
2,171.48
|
0.00
|
—
|
—
|
| Receivables |
|
—
|
82.81
+119.99%
|
37.64
+459.18%
|
6.73
|
| Accounts Receivable |
|
—
|
53.55
+76.26%
|
30.38
+683.37%
|
3.88
|
| Taxes Receivable |
|
—
|
1.83
-22.45%
|
2.36
-17.45%
|
2.85
|
| Accrued Interest Receivable |
|
—
|
27.44
+458.99%
|
4.91
|
—
|
| Inventory |
|
—
|
35.25
+1176.75%
|
2.76
|
0.00
|
| Prepaid Assets |
|
—
|
55.10
-9.42%
|
60.83
+13.97%
|
53.37
|
| Restricted Cash |
|
—
|
5.37
+7.10%
|
5.01
+28.39%
|
3.90
|
| Assets Held For Sale Current |
|
0.00
-100.00%
|
156.27
|
—
|
—
|
| Other Current Assets |
|
113.17
+40.40%
|
80.61
+418.99%
|
15.53
-29.78%
|
22.12
|
| Total Non Current Assets |
|
436.88
-10.96%
|
490.65
-16.98%
|
591.02
+34.75%
|
438.61
|
| Net PPE |
|
101.08
+70.38%
|
59.32
-35.75%
|
92.34
+6.20%
|
86.95
|
| Gross PPE |
|
101.08
+70.38%
|
59.32
-35.75%
|
92.34
+6.20%
|
86.95
|
| Other Properties |
|
101.08
+70.38%
|
59.32
-35.75%
|
92.34
+6.20%
|
86.95
|
| Goodwill And Other Intangible Assets |
|
—
|
137.84
-4.86%
|
144.88
|
0.00
|
| Investments And Advances |
|
302.94
+22.27%
|
247.75
-18.59%
|
304.32
-6.60%
|
325.83
|
| Other Investments |
|
302.94
+22.27%
|
247.75
-18.59%
|
304.32
-6.60%
|
325.83
|
| Other Non Current Assets |
|
32.86
-82.10%
|
183.58
+271.00%
|
49.48
+91.62%
|
25.82
|
| Total Liabilities Net Minority Interest |
|
249.74
-67.73%
|
773.95
-1.03%
|
782.02
+49.33%
|
523.70
|
| Current Liabilities |
|
149.41
-43.99%
|
266.76
-2.09%
|
272.45
+47.77%
|
184.37
|
| Payables And Accrued Expenses |
|
84.47
-9.49%
|
93.33
-29.69%
|
132.75
+11.97%
|
118.56
|
| Payables |
|
24.11
+1.28%
|
23.80
-37.97%
|
38.37
+8.73%
|
35.29
|
| Accounts Payable |
|
23.69
+68.87%
|
14.03
-62.92%
|
37.83
+9.39%
|
34.58
|
| Current Accrued Expenses |
|
60.37
-13.18%
|
69.53
-26.33%
|
94.37
+13.34%
|
83.27
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
53.93
+8.09%
|
49.89
-9.60%
|
55.19
+24.68%
|
44.26
|
| Total Tax Payable |
|
0.42
-95.74%
|
9.77
+1703.14%
|
0.54
-23.45%
|
0.71
|
| Income Tax Payable |
|
0.42
-95.74%
|
9.77
+1703.14%
|
0.54
-23.45%
|
0.71
|
| Current Debt And Capital Lease Obligation |
|
9.84
+9.77%
|
8.97
-82.89%
|
52.41
+359.84%
|
11.40
|
| Current Debt |
|
—
|
12.00
-70.53%
|
40.72
|
—
|
| Other Current Borrowings |
|
—
|
12.00
-70.53%
|
40.72
|
—
|
| Current Capital Lease Obligation |
|
9.84
+9.77%
|
8.97
-23.32%
|
11.69
+2.59%
|
11.40
|
| Current Deferred Liabilities |
|
1.17
-71.98%
|
4.17
-66.51%
|
12.44
+22.64%
|
10.15
|
| Current Deferred Revenue |
|
1.17
-71.98%
|
4.17
-66.51%
|
12.44
+22.64%
|
10.15
|
| Other Current Liabilities |
|
—
|
110.41
+5182.54%
|
2.09
-80.75%
|
10.86
|
| Total Non Current Liabilities Net Minority Interest |
|
100.33
-80.22%
|
507.19
-0.47%
|
509.57
+50.17%
|
339.33
|
| Liabilities Heldfor Sale Non Current |
|
0.00
-100.00%
|
433.94
|
—
|
—
|
| Long Term Debt And Capital Lease Obligation |
|
90.33
+100.64%
|
45.02
-89.51%
|
428.99
+57.43%
|
272.49
|
| Long Term Debt |
|
—
|
430.59
+14.67%
|
375.51
+78.80%
|
210.03
|
| Long Term Capital Lease Obligation |
|
90.33
+100.64%
|
45.02
-15.81%
|
53.48
-14.39%
|
62.47
|
| Non Current Deferred Liabilities |
|
—
|
—
|
—
|
13.74
|
| Non Current Deferred Revenue |
|
—
|
—
|
—
|
13.74
|
| Other Non Current Liabilities |
|
10.00
-64.57%
|
28.23
-64.97%
|
80.58
+20.56%
|
66.83
|
| Stockholders Equity |
|
4,687.60
-21.46%
|
5,968.58
+415.53%
|
1,157.77
-30.13%
|
1,656.94
|
| Common Stock Equity |
|
4,687.60
-21.46%
|
5,968.58
+415.53%
|
1,157.77
-30.13%
|
1,656.94
|
| Capital Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
695.94
-13.73%
|
806.68
+6.12%
|
760.14
+9.38%
|
694.98
|
| Ordinary Shares Number |
|
695.94
-13.73%
|
806.68
+6.12%
|
760.14
+9.38%
|
694.98
|
| Additional Paid In Capital |
|
4,562.11
-15.46%
|
5,396.49
+9.39%
|
4,933.14
+11.57%
|
4,421.61
|
| Retained Earnings |
|
116.06
-79.86%
|
576.17
+115.27%
|
-3,772.75
-36.51%
|
-2,763.72
|
| Gains Losses Not Affecting Retained Earnings |
|
9.44
+331.15%
|
-4.08
-56.02%
|
-2.62
-176.64%
|
-0.95
|
| Minority Interest |
|
499.59
+4.09%
|
479.95
+6.70%
|
449.82
+11.21%
|
404.49
|
| Other Equity Adjustments |
|
9.44
+331.15%
|
-4.08
-56.02%
|
-2.62
-176.64%
|
-0.95
|
| Total Equity Gross Minority Interest |
|
5,187.20
-19.56%
|
6,448.53
+301.13%
|
1,607.59
-22.02%
|
2,061.43
|
| Total Capitalization |
|
4,687.60
-21.46%
|
5,968.58
+289.27%
|
1,533.28
-17.87%
|
1,866.97
|
| Working Capital |
|
4,850.65
-24.97%
|
6,465.07
+323.62%
|
1,526.14
-22.22%
|
1,962.16
|
| Invested Capital |
|
4,687.60
-21.46%
|
5,968.58
+279.20%
|
1,574.00
-15.69%
|
1,866.97
|
| Total Debt |
|
100.17
+85.55%
|
53.99
-88.79%
|
481.40
+69.57%
|
283.89
|
| Capital Lease Obligations |
|
100.17
+85.55%
|
53.99
-17.16%
|
65.17
-11.77%
|
73.87
|
| Net Tangible Assets |
|
4,687.60
-21.46%
|
5,968.58
+489.27%
|
1,012.88
-38.87%
|
1,656.94
|
| Tangible Book Value |
|
4,687.60
-21.46%
|
5,968.58
+489.27%
|
1,012.88
-38.87%
|
1,656.94
|
| Current Provisions |
|
—
|
23.28
+32.49%
|
17.57
|
—
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-839.45
-9.69%
|
-765.27
+9.26%
|
-843.39
-24.44%
|
-677.73
|
| Cash Flow From Continuing Operating Activities |
|
-839.45
-9.69%
|
-765.27
+9.26%
|
-843.39
-24.44%
|
-677.73
|
| Net Income From Continuing Operations |
|
-356.73
-108.43%
|
4,231.21
+479.32%
|
-1,115.46
-20.71%
|
-924.12
|
| Depreciation Amortization Depletion |
|
14.07
-36.15%
|
22.04
+16.86%
|
18.86
+217.89%
|
5.93
|
| Depreciation And Amortization |
|
14.07
-36.15%
|
22.04
+16.86%
|
18.86
+217.89%
|
5.93
|
| Other Non Cash Items |
|
-102.47
-206.70%
|
96.04
+155.77%
|
37.55
-54.63%
|
82.76
|
| Stock Based Compensation |
|
289.03
+44.78%
|
199.63
-8.34%
|
217.78
-61.45%
|
564.96
|
| Operating Gains Losses |
|
-481.15
+91.06%
|
-5,381.18
-18280.86%
|
-29.28
+94.26%
|
-510.27
|
| Gain Loss On Investment Securities |
|
—
|
—
|
—
|
-505.23
|
| Unrealized Gain Loss On Investment Securities |
|
-55.19
-215.04%
|
47.97
+130.47%
|
20.82
-76.15%
|
87.29
|
| Change In Working Capital |
|
-77.05
-504.76%
|
19.04
+200.00%
|
6.34
-59.63%
|
15.72
|
| Change In Payables And Accrued Expense |
|
-28.24
-133.30%
|
84.81
+37.04%
|
61.89
-6.23%
|
66.00
|
| Change In Accrued Expense |
|
-10.07
-116.21%
|
62.13
+8.00%
|
57.53
+13.70%
|
50.59
|
| Change In Payable |
|
-18.17
-180.09%
|
22.68
+420.39%
|
4.36
-71.70%
|
15.40
|
| Change In Account Payable |
|
-18.17
-180.09%
|
22.68
+420.39%
|
4.36
-71.70%
|
15.40
|
| Change In Other Working Capital |
|
—
|
—
|
3.30
+121.43%
|
-15.41
|
| Change In Other Current Assets |
|
-33.83
+47.95%
|
-64.99
-32.40%
|
-49.09
-75.31%
|
-28.00
|
| Change In Other Current Liabilities |
|
-14.98
-1805.85%
|
-0.79
+87.82%
|
-6.46
+5.97%
|
-6.87
|
| Investing Cash Flow |
|
-1,766.29
-133.94%
|
5,203.62
+11854.55%
|
-44.27
-114.60%
|
303.30
|
| Cash Flow From Continuing Investing Activities |
|
-1,766.29
-133.94%
|
5,203.62
+11854.55%
|
-44.27
-114.60%
|
303.30
|
| Net PPE Purchase And Sale |
|
-4.60
-232.78%
|
-1.38
+89.11%
|
-12.69
+27.22%
|
-17.44
|
| Purchase Of PPE |
|
-4.60
-232.78%
|
-1.38
+89.11%
|
-12.69
+27.22%
|
-17.44
|
| Capital Expenditure |
|
-4.60
-232.78%
|
-1.38
+89.11%
|
-12.69
+27.22%
|
-17.44
|
| Net Investment Purchase And Sale |
|
-2,101.52
|
0.00
|
0.00
-100.00%
|
320.17
|
| Purchase Of Investment |
|
-4,061.52
|
0.00
|
0.00
|
—
|
| Sale Of Investment |
|
1,960.00
|
0.00
|
0.00
-100.00%
|
320.17
|
| Net Business Purchase And Sale |
|
229.36
+720.18%
|
-36.98
-134.29%
|
107.86
+276651.28%
|
-0.04
|
| Purchase Of Business |
|
-31.22
+63.04%
|
-84.48
-1159.81%
|
-6.71
-17094.87%
|
-0.04
|
| Gain Loss On Sale Of Business |
|
-379.61
-1058.35%
|
-32.77
-11.94%
|
-29.28
-480.76%
|
-5.04
|
| Net Other Investing Changes |
|
110.47
-97.89%
|
5,241.99
+3859.48%
|
-139.43
-23339.00%
|
0.60
|
| Financing Cash Flow |
|
-1,219.79
-390.87%
|
419.36
-16.04%
|
499.46
+62.80%
|
306.79
|
| Cash Flow From Continuing Financing Activities |
|
-1,219.79
-390.87%
|
419.36
-16.04%
|
499.46
+62.80%
|
306.79
|
| Net Issuance Payments Of Debt |
|
-52.75
-71.81%
|
-30.70
-123.66%
|
129.75
+776.13%
|
14.81
|
| Issuance Of Debt |
|
0.00
|
0.00
-100.00%
|
159.90
+339.28%
|
36.40
|
| Repayment Of Debt |
|
-52.75
-71.81%
|
-30.70
-1.86%
|
-30.14
-39.62%
|
-21.59
|
| Long Term Debt Issuance |
|
0.00
|
0.00
-100.00%
|
159.90
+339.28%
|
36.40
|
| Long Term Debt Payments |
|
-52.75
-71.81%
|
-30.70
-1.86%
|
-30.14
-39.62%
|
-21.59
|
| Net Long Term Debt Issuance |
|
-52.75
-71.81%
|
-30.70
-123.66%
|
129.75
+776.13%
|
14.81
|
| Net Common Stock Issuance |
|
-1,180.45
-369.17%
|
438.56
+15.50%
|
379.71
|
0.00
|
| Common Stock Payments |
|
-1,293.23
|
0.00
|
0.00
|
—
|
| Repurchase Of Capital Stock |
|
-1,293.23
|
0.00
|
0.00
|
—
|
| Proceeds From Stock Option Exercised |
|
50.62
-8.34%
|
55.23
+1664.50%
|
3.13
-96.88%
|
100.41
|
| Net Other Financing Charges |
|
-37.22
+14.87%
|
-43.72
-232.91%
|
-13.13
-106.85%
|
191.57
|
| Changes In Cash |
|
-3,825.54
-178.75%
|
4,857.72
+1351.34%
|
-388.20
-473.90%
|
-67.64
|
| Effect Of Exchange Rate Changes |
|
0.75
+21.27%
|
0.62
-90.19%
|
6.28
|
0.00
|
| Beginning Cash Position |
|
6,550.45
+287.12%
|
1,692.12
-18.41%
|
2,074.03
-3.16%
|
2,141.68
|
| End Cash Position |
|
2,725.66
-58.39%
|
6,550.45
+287.12%
|
1,692.12
-18.41%
|
2,074.03
|
| Free Cash Flow |
|
-844.05
-10.10%
|
-766.65
+10.45%
|
-856.08
-23.15%
|
-695.16
|
| Interest Paid Supplemental Data |
|
5.96
-41.93%
|
10.27
+93.63%
|
5.30
-4.19%
|
5.54
|
| Income Tax Paid Supplemental Data |
|
61.91
+401.13%
|
12.35
+140.91%
|
5.13
+459.83%
|
0.92
|
| Amortization Of Securities |
|
-69.96
|
0.00
|
0.00
|
—
|
| Change In Interest Payable |
|
0.00
-100.00%
|
21.98
+18.34%
|
18.57
|
—
|
| Common Stock Issuance |
|
112.78
-74.28%
|
438.56
+15.50%
|
379.71
|
0.00
|
| Earnings Losses From Equity Investments |
|
—
|
—
|
—
|
0.00
|
| Issuance Of Capital Stock |
|
112.78
-74.28%
|
438.56
+15.50%
|
379.71
|
0.00
|
| Sale Of Business |
|
260.59
+448.60%
|
47.50
-58.54%
|
114.56
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-22 View
- 42026-04-22 View
- 42026-04-22 View
- 42026-04-21 View
- 42026-04-21 View
- 42026-04-21 View
- 42026-04-20 View
- 42026-04-10 View
- 42026-04-02 View
- 8-K2026-04-02 View
- 42026-04-01 View
- 42026-04-01 View
- 42026-03-30 View
- 42026-03-24 View
- 42026-03-24 View
- 42026-03-19 View
- 42026-03-18 View
- 8-K2026-03-03 View
- 8-K2026-03-03 View
- 42026-02-24 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|